![Mitsunaga Tada](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Mitsunaga Tada
Nessuna posizione attualmente
Storia della carriera di Mitsunaga Tada
Precedenti posizioni note di Mitsunaga Tada
Società | Posizione | Inizio | Fine |
---|---|---|---|
R-TECH UENO, LTD. | Direttore/Membro del Consiglio | - | 24/06/2014 |
Ridgeway Capital Partners Ltd.
![]() Ridgeway Capital Partners Ltd. Investment ManagersFinance Ridgeway Capital Partners Ltd. (RCP) is an independent, partner-owned venture capital firm which specializes in private equity investments. Established in 2001 as Principal Investment Group of Investment Banking Headquarters, Orix Corporation, the firm became OPE Partners Ltd. in 2004 when they were spun-off from Orix Corporation. In 2006, the firm's partners launched an MBO, changing the firm's name to Ridgeway Capital Partners Ltd. in 2007. Headquartered in Tokyo, RCP provides private equity investments and management consulting services. | Membro del Comitato di Investimento | 01/04/2006 | 18/01/2008 |
Formazione di Mitsunaga Tada
Kyoto University | Undergraduate Degree |
Statistiche
Distribuzione geografica
Giappone | 4 |
Posizioni
Investment Committee Member | 1 |
Undergraduate Degree | 1 |
Director/Board Member | 1 |
Settori
Health Technology | 2 |
Consumer Services | 2 |
Finance | 2 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
Aziende private | 2 |
---|---|
R-Tech Ueno, Ltd.
![]() R-Tech Ueno, Ltd. Pharmaceuticals: MajorHealth Technology R-Tech Ueno Ltd. engages in the research and development, manufacture and sale of pharmaceutical products. It operates through the following business divisions: New Pharmaceutical Research and Development, Pharmaceutical Manufacture and Sale, and Pharmaceutical Development Support and Contract Manufacturing Services. The New Pharmaceutical Research and Development business provides development for unmet medical needs area, orphan drug area, and anti-aging area. The Pharmaceutical Manufacture and Sale business handles the manufacture and sale of Rescula Eye Drops for glaucoma and ocular hypertension. The Pharmaceutical Development Support and Contract Manufacturing Services business covers the manufacture and sale of AMITIZA capsules for chronic idiopathic constipation. It also accepts contract manufacturing of eye drops, liquid drugs and liquid-filled hard capsules. The company was founded by Ryuji Ueno and Sachiko Kuno in September 1989 and is headquartered in Tokyo, Japan. | Health Technology |
Ridgeway Capital Partners Ltd.
![]() Ridgeway Capital Partners Ltd. Investment ManagersFinance Ridgeway Capital Partners Ltd. (RCP) is an independent, partner-owned venture capital firm which specializes in private equity investments. Established in 2001 as Principal Investment Group of Investment Banking Headquarters, Orix Corporation, the firm became OPE Partners Ltd. in 2004 when they were spun-off from Orix Corporation. In 2006, the firm's partners launched an MBO, changing the firm's name to Ridgeway Capital Partners Ltd. in 2007. Headquartered in Tokyo, RCP provides private equity investments and management consulting services. | Finance |
- Borsa valori
- Insiders
- Mitsunaga Tada
- Esperienza